Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Tofacitinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 13,876Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    DeepCure Presents Ex Vivo Data For DC-9476 At ACR Convergence
    DeepCure Presents Ex Vivo Data For DC-9476 At ACR Convergence

    24 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241024256878/en

    BUSINESSWIRE
    24 Oct 2024
    Share Share
    Biora Therapeutics Presents Phase 1 Data For BT-600 At KOL Event
    Biora Therapeutics Presents Phase 1 Data For BT-600 At KOL Event

    18 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/18/2915229/0/en/Biora-Therapeutics-Announces-Supplemental-Data-from-Phase-1-Clinical-Trial-of-BT-600-as-Presented-at-KOL-Event.html

    GLOBENEWSWIRE
    18 Jul 2024
    Share Share
    Biora To Host KOL Event On NaviCap Platform And BT-600 Trial Results
    Biora To Host KOL Event On NaviCap Platform And BT-600 Trial Results

    08 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/08/2909602/0/en/Biora-Therapeutics-to-Host-Virtual-KOL-Event-on-NaviCap-Targeted-Oral-Delivery-Platform-and-Results-from-Phase-1-Clinical-Trial-of-BT-600-on-July-17-2024.html

    GLOBENEWSWIRE
    08 Jul 2024
    Share Share
    Biora Therapeutics Announces Positive Clinical Trial Results for BT-600
    Biora Therapeutics Announces Positive Clinical Trial Results for BT-600

    01 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/01/2906658/0/en/Biora-Therapeutics-Announces-Positive-Clinical-Trial-Results-for-BT-600.html

    GLOBENEWSWIRE
    01 Jul 2024
    Share Share
    Aurobindo 's Generic Betamethasone Dipropionate Receives Approval in the U.S
    Aurobindo 's Generic Betamethasone Dipropionate Receives Approval in the U.S

    04 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218462

    FDA
    04 Jun 2024
    Share Share
    Organovo Shows FXR314 IBD Combination Potential At DDW2024
    Organovo Shows FXR314 IBD Combination Potential At DDW2024

    21 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/21/2885553/37000/en/Organovo-Data-Presented-at-Digestive-Disease-Week-DDW2024-Demonstrating-Potential-for-FXR314-as-Combination-Therapy-with-Tofacitinib-for-Inflammatory-Bowel-Disease.html

    GLOBENEWSWIRE
    21 May 2024
    Share Share